- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03262246
Cerebral Infarction and White Substance in Angiopathy Cerebral Amyloid
The cerebral amyloïd angiopathy ( AAC) is a disease characterized by deposits of beta-amyloid peptids in the walls of the arteries of young and average calibre of the brain and the leptomeninx. The incidence of the AAC increases strongly with the age and represents a major cause of spontaneous brain haemorrhage to people over 60. The main demonstration is the lobar brain haemorrhage, the other ones are bleedings under arachnoid cortical and microbleedings leading to cognitive decline.
Anatomical studies reported the presence of cortical infarcts in patients having amyloïd deposits suggesting an association between asymptomatic cortical cerebral infarcts and AAC.
However prevalence and meaning of these infarcts in patients having an AAC remain badly known because of studies on low number of patients and the rarity of radiological analyses of these infarcts .A better knowledge of these asymptomatic cortical infarcts would allow to dread better cognitive disorders(confusions) presented by these patients, and to develop preventive strategies.
Besides, the risk factors of severity of the AAC are little studied.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Ile-de-France
-
Paris, Ile-de-France, France, 75014
- Groupe hospitalier Paris Saint Joseph
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- age>55
- hospitalized in CAEN hospital and Paris St Joseph Hospital between 1st january 2011 and 31 december 2015 for cerebral haemorrhage with MRI images diagnosing cerebral amyloid angiopathy.
Exclusion Criteria:
- Insufficient MRI images quality without FLAI sequence, T2 GRE
- disease with same radiologic and clinical signs that cerebral amyloid angiopathy.
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
number of patient with cerebral infarction and associated factors in a cohort of cerebral amyloid angiopathy patients
Time Frame: 1day
|
1day
|
Collaborators and Investigators
Investigators
- Principal Investigator: HODEL Jérome, Professor, GHPSJ
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Ischemia
- Pathologic Processes
- Necrosis
- Cardiovascular Diseases
- Vascular Diseases
- Metabolic Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Brain Ischemia
- Proteostasis Deficiencies
- Stroke
- Brain Infarction
- Infarction
- Amyloidosis
- Cerebral Infarction
Other Study ID Numbers
- ISAAC
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Amyloid Angiopathy
-
University Hospital, MontpellierCentre Hospitalier Universitaire de Nīmes; University Hospital, Toulouse; Perpignan... and other collaboratorsTerminatedCerebral Amyloid Angiopathy Related Inflammation
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...RecruitingCerebral Amyloid AngiopathyItaly
-
PfizerCompletedCerebral Amyloid AngiopathyCanada, United States, Netherlands, France, United Kingdom
-
University Hospital Inselspital, BerneRecruitingCerebral Amyloid Angiopathy | Cadasil | Small Vessel Cerebrovascular Disease | CAA - Cerebral Amyloid AngiopathySwitzerland
-
University Hospital Inselspital, BerneRecruitingCerebral Small Vessel Diseases | Intracerebral Hemorrhage | CAA - Cerebral Amyloid AngiopathySwitzerland
-
Centre Hospitalier Universitaire de NīmesCompletedCerebral Amyloid Angiopathy | Hypertensive ArteriopathyFrance
-
Anna OlczakCompletedCerebral Amyloid AngiopathyPoland
-
Amydis Inc.National Institutes of Health (NIH); National Institute on Aging (NIA)Recruiting
-
Leiden University Medical CenterRecruiting
-
Martin DichgansRecruitingCerebral Amyloid AngiopathyGermany
Clinical Trials on medical report consultation
-
Centre Leon BerardUniversity of Paris 5 - Rene Descartes; Institut d'Hématologie et d'Oncologie...Recruiting
-
University Paris 7 - Denis DiderotCompletedPharyngitis | Viral Gastro EnteritisFrance
-
Murielle SurquinCompleted
-
Philipps University Marburg Medical CenterUnknownHealthy ParticipantsGermany
-
University Hospital, RouenUnknownColoRectal CancerFrance
-
Centre Francois BaclesseRecruitingBrain Tumor | Radiotherapy | Paramedical Consultation | Proton TherapyFrance
-
Poitiers University HospitalActive, not recruitingSurgery | Female Breast Cancer | 75 Years Old and MoreFrance
-
National Taiwan University HospitalNot yet recruiting
-
Academia Sinica, TaiwanTaipei Veterans General Hospital, TaiwanTerminated